Status:
TERMINATED
EpiRetinal Membrane Peeling and Internal Limiting Membrane
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Epiretinal Membrane
Macular Pucker
Eligibility:
All Genders
18-99 years
Brief Summary
To study and compare visual acuity in patients undergoing removal of the epiretinal membrane with and without the removal of the internal limiting membrane at baseline versus 6 month.
Detailed Description
This prospective cohort study includes 2 arms : with and without internal limiting membrane (ILM) peeling. Each patient undergo the same procedure : first of all pars plana vitrectomy, then internal ...
Eligibility Criteria
Inclusion
- adult up to 18 years old,
- diagnosed and treated surgically
Exclusion
- proliferative diabetic retinopathy,
- ocular trauma,
- central veinous occlusion,
- intra-ocular tumor, total retinal detachment,
- central visual field loss in glaucomatous patients
Key Trial Info
Start Date :
May 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04802265
Start Date
May 21 2021
End Date
August 1 2021
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, AURA, France, 63000